Aevi Genomic Medicine, Inc. Total Assets
Aevi Genomic Medicine, Inc. had Total Assets of $2.80 million as of 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Balance Sheet › Assets
us-gaap:Assets · last filed 2019-11-14
- 2019-09-30: Assets $2.80M.
- 2019-06-30: Assets $4.02M.
- 2019-03-31: Assets $7.62M.
- 2018-12-31: Assets $12.28M.
| Period end | Assets |
|---|---|
| 2019-09-30 | $2.80M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $4.02M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $7.62M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $12.28M 10-Q · filed 2019-11-14 |
| 2018-09-30 | $20.19M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $20.23M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $27.43M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $34.76M 10-K · filed 2019-03-29 |
| 2017-09-30 | $16.95M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $22.74M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $30.53M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $40.56M 10-K · filed 2018-03-13 |
| 2016-09-30 | $48.33M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $55.30M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $45.16M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $54.26M 10-K · filed 2017-03-09 |
| 2015-09-30 | $19.59M 10-Q · filed 2015-10-22 |
| 2015-06-30 | $24.76M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $27.41M 10-Q · filed 2015-04-20 |
| 2014-12-31 | $34.28M 10-K · filed 2016-02-26 |
| 2014-09-30 | $15.87M 10-Q · filed 2014-10-15 |
| 2014-06-30 | $18.05M 10-Q · filed 2014-07-16 |
| 2014-03-31 | $20.25M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $23.09M 10-K · filed 2015-02-13 |
| 2013-09-30 | $28.32M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $31.49M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $33.66M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $7.71M 10-K · filed 2014-02-20 |
| 2012-09-30 | $10.34M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $11.47M 10-Q · filed 2013-08-06 |
| 2012-03-31 | $5.20M 10-Q · filed 2012-05-14 |
| 2011-12-31 | $6.86M 10-K · filed 2013-03-14 |
| 2011-09-30 | $9.70M 10-Q · filed 2012-11-14 |
| 2011-06-30 | $11.92M 10-Q/A · filed 2012-09-04 |
| 2010-12-31 | $5.12M 10-K · filed 2012-03-06 |
| 2010-09-30 | $6.20M 10-Q · filed 2011-11-10 |
| 2010-06-30 | $2.22M 10-Q/A · filed 2011-09-08 |